文献速递流行病学与生物统计医学教育与科研方法

物理状况治疗随机对照试验的排除率:一项系统综述

Exclusion rates in randomized controlled trials of treatments for physical conditions: a systematic review.
PubMed 文献 · Trials · 2020-02-26

该系统综述检索 Medline 和 Embase 至 2018 年 2 月 11 日,纳入 50 项研究、覆盖 31 种物理状况的 305 项试验,评估临床人群被 RCT 排除的比例。排除率从 0% 到 100% 不等,中位排除率为 77.1%(四分位距 55.5%–89.0%),常见慢性病试验排除率亦高。多数试验排除了多数患者,且近年未见显著变化。

要点

  • RCT 排除率中位数为 77.1%,四分位距 55.5%–89.0%。
  • 高血压、2 型糖尿病、COPD、哮喘试验的中位排除率分别为 83.0%、81.7%、84.3%、96.0%。
  • 近四分之一试验排除超过 90% 患者,超过半数试验排除至少四分之三患者。

核心结论

  • 所考察的物理状况治疗试验大多排除了大多数患者。
  • 近四分之一试验排除超过 90% 患者,超过半数试验排除至少四分之三患者,五分之四试验排除至少一半患者。
  • 排除标准多涉及年龄、合并症和合并用药,而预期寿命或功能状态等隐性标准通常未被考察。

研究设计与样本

  • 系统综述,检索 Medline 和 Embase 自建库至 2018 年 2 月 11 日。
  • 两位评审员独立完成筛选、全文审阅、数据提取和偏倚风险评估。
  • 纳入 50 项研究,报告 31 种物理状况的 305 项试验的排除率。
  • 主要结局为临床人群中会被每项试验排除的患者百分比。
  • 亚组分析考察人群设置、发表日期和资金来源对排除的影响。

主要发现

  • 估计排除率从 0% 到 100% 不等,中位排除率为 77.1%(四分位距 55.5%–89.0%)。
  • 常见慢性病试验中位排除率:高血压 83.0%、2 型糖尿病 81.7%、慢性阻塞性肺疾病 84.3%、哮喘 96.0%。
  • 最常见排除标准涉及年龄、合并症和合并用药。
  • 无证据表明排除率随临床人群性质或试验资金来源而变化。
  • 较新试验与较老试验的排除率无统计学显著变化。

关键数值与推荐

  • 中位排除率 77.1%(四分位距 55.5%–89.0%)。
  • 高血压试验中位排除率 83.0%。
  • 2 型糖尿病试验中位排除率 81.7%。
  • 慢性阻塞性肺疾病试验中位排除率 84.3%。
  • 哮喘试验中位排除率 96.0%。

临床怎么用

  • 解读 RCT 结果时需考虑高排除率可能限制其向真实临床人群的外推。
  • 对老年人、合并症和合并用药患者,试验排除日益不可持续。
  • 设计试验时应量化并报告排除标准对代表性和外推性的影响。

局限性

  • 大多数研究仅应用部分入选标准,排除率可能被低估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The generalisability of randomized controlled trials (RCTs) can be uncertain because the impact of exclusion criteria is rarely quantified. The aim of this study was to systematically review studies examining the percentage of clinical populations with a physical health condition who would be excluded by RCTs of treatments for that condition. METHODS: Medline and Embase were searched from inception to Feb 11th 2018. Two reviewers independently completed screening, full-text review, data extraction and risk-of-bias assessment. The primary outcome was the percentage of patients in the clinical population who would have been excluded from each examined trial. Subgroup analyses examined exclusion by population setting, publication date and funding source. RESULTS: Titles/abstracts (20,754) were screened, and 50 studies were included which reported exclusion rates from 305 trials of treatments in 31 physical conditions. Estimated rates of exclusion from trials varied from 0% to 100%, and the median exclusion rate was 77.1% of patients (interquartile range 55.5% to 89.0% exclusion). Median exclusion rates for trials in common chronic conditions were high, including hypertension 83.0%, type 2 diabetes 81.7%, chronic obstructive pulmonary disease 84.3%, and asthma 96.0%. The most commonly applied exclusion criteria related to age, co-morbidity and co-prescribing, whereas more implicit criteria relating to life expectancy or functional status were not typically examined. There was no evidence that exclusion varied by the nature of the clinical population in which exclusion was evaluated or trial funding source. There was no statistically significant change in exclusion rates in more recent compared with older trials. CONCLUSIONS: The majority of trials of treatments for physical conditions examined excluded the majority of patients with the condition being treated. Almost a quarter of the trials studied excluded over 90% of patients, more than half of trials excluded at least three quarters of patients, and four out of five trials excluded at least half of patients. A limitation is that most studies applied only a subset of eligibility criteria, so exclusion rates are likely under-estimated. Exclusion from trials of older people and people with co-morbidity and co-prescribing is increasingly untenable given population aging and increasing multimorbidity. TRIAL REGISTRATION: PROSPERO registration CRD42016042282.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. He J, Morales DR, Guthrie B, et al. Exclusion rates in randomized controlled trials of treatments for physical conditions: a systematic review. Trials. 2020. PMID: 32102686. doi:10.1186/s13063-020-4139-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。